암 악액질 시장 : 치료법, 기능, 유통 채널별 - 세계 전망(2025-2030년)

The Cancer Cachexia Market was valued at USD 2.09 billion in 2023, expected to reach USD 2.24 billion in 2024, and is projected to grow at a CAGR of 7.53%, to USD 3.48 billion by 2030.

Cancer cachexia is a complex syndrome characterized by severe weight loss, muscle wasting, and reduced food intake, frequently observed in cancer patients. The condition's definition extends beyond mere anorexia, encompassing metabolic changes that lead to significant morbidity and mortality risks. As a market research analyst, the necessity for understanding this syndrome lies in developing effective treatment options to improve the quality of life and survival rates of affected patients. Key applications include pharmaceuticals, nutritional supplements, and supportive care therapies, with end-use spanning hospitals, cancer treatment centers, and home care settings. Market growth is driven by increasing cancer prevalence, demanding more personalized and comprehensive therapeutic solutions. The growing focus on palliative care and patient-centric treatment further propels the market's expansion.

Factors impacting growth include advancements in biotechnology and ongoing research into metabolic pathways, providing opportunities for innovative drug development. The growing geriatric population, susceptible to cancer and, hence, cachexia, also boosts market potential. However, challenges such as complex drug development processes, high costs, and stringent regulatory requirements pose significant barriers. Furthermore, the heterogeneity of cancer cachexia, influenced by various cancer types and stages, complicates the standardization of treatment protocols.

Opportunities exist in exploring multi-modal treatment approaches, combining pharmacological and non-pharmacological interventions. Emerging research areas include understanding molecular mechanisms driving cachexia, which could lead to targeted therapies. Emphasis on personalized medicine and biomarkers offers potential for innovative products that cater to individual patient needs. Collaborations between pharmaceutical companies, research institutions, and healthcare providers can expedite these developments.

The market's nature is highly dynamic, driven by continual advancements in cancer research and therapeutic technologies. Companies focusing on developing integrated treatment regimes, improving patient nutrition, and enhancing overall patient management systems stand to gain a competitive edge. Identifying niche markets within geriatric oncology and enhancing patient education about cachexia management can further stimulate growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cancer Cachexia Market

The Cancer Cachexia Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of cachexia amongst the geriatric population
  • Presence of adequate reimbursement policies
  • Improving healthcare infrastructure and rise in awareness to treat cancer cachexia
• Market Restraints
  • High cost of treatment
• Market Opportunities
  • Technological advancements for the treatment of cancer cachexia
  • Rising number of research and development activities for the discovery of therapeutic drugs
• Market Challenges
  • Implementation of stringent regulatory requirements and lengthy FDA approval

Porter's Five Forces: A Strategic Tool for Navigating the Cancer Cachexia Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cancer Cachexia Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cancer Cachexia Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cancer Cachexia Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cancer Cachexia Market

A detailed market share analysis in the Cancer Cachexia Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cancer Cachexia Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cancer Cachexia Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cancer Cachexia Market

A strategic analysis of the Cancer Cachexia Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cancer Cachexia Market, highlighting leading vendors and their innovative profiles. These include AAVogen Inc., Actimed Therapeutics Ltd., Aeterna Zentaris Inc., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Fresenius Kabi AG, Green Cross Wellbeing Corporation, Helsinn Healthcare SA, INOVIO Pharmaceuticals Inc., Mankind Pharma Ltd., Merck & Co. Inc., MetaFines Co., Ltd., NeuBase Therapeutics, Inc., NGM Biopharmaceuticals Inc., Ono Pharmaceutical Co., Ltd., Pfizer Inc., and Tetra Bio-Pharma.

Market Segmentation & Coverage

This research report categorizes the Cancer Cachexia Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Therapy, market is studied across Combination Therapies, Corticosteroids, and Progestogens.
• Based on Functionality, market is studied across Appetite Stimulators and Weight Loss Stabilizers.
• Based on Distribution Channel, market is studied across Hospital Stores, Online Pharmacy, and Retail Pharmacy Stores.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of cachexia amongst the geriatric population
    • 5.1.1.2. Presence of adequate reimbursement policies
    • 5.1.1.3. Improving healthcare infrastructure and rise in awareness to treat cancer cachexia
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements for the treatment of cancer cachexia
    • 5.1.3.2. Rising number of research and development activities for the discovery of therapeutic drugs
  • 5.1.4. Challenges
    • 5.1.4.1. Implementation of stringent regulatory requirements and lengthy FDA approval
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cancer Cachexia Market, by Therapy

• 6.1. Introduction
• 6.2. Combination Therapies
• 6.3. Corticosteroids
• 6.4. Progestogens

7. Cancer Cachexia Market, by Functionality

• 7.1. Introduction
• 7.2. Appetite Stimulators
• 7.3. Weight Loss Stabilizers

8. Cancer Cachexia Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospital Stores
• 8.3. Online Pharmacy
• 8.4. Retail Pharmacy Stores

9. Americas Cancer Cachexia Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cancer Cachexia Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cancer Cachexia Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AAVogen Inc.
• 2. Actimed Therapeutics Ltd.
• 3. Aeterna Zentaris Inc.
• 4. Aphios Corporation
• 5. Artelo Biosciences Inc.
• 6. AVEO Pharmaceuticals Inc.
• 7. Boehringer Ingelheim International GmbH
• 8. Bristol-Myers Squibb Company
• 9. Fresenius Kabi AG
• 10. Green Cross Wellbeing Corporation
• 11. Helsinn Healthcare SA
• 12. INOVIO Pharmaceuticals Inc.
• 13. Mankind Pharma Ltd.
• 14. Merck & Co. Inc.
• 15. MetaFines Co., Ltd.
• 16. NeuBase Therapeutics, Inc.
• 17. NGM Biopharmaceuticals Inc.
• 18. Ono Pharmaceutical Co., Ltd.
• 19. Pfizer Inc.
• 20. Tetra Bio-Pharma